The Deadly Ebola Outbreak That's Proving Almost Impossible to Control
STOREEN

The Deadly Ebola Outbreak That's Proving Almost Impossible to Control

A new Ebola outbreak in the DRC caused by the Bundibugyo virus has killed over 223 people. No vaccine, armed violence, and US funding cuts are fueling the crisis.

June 4, 2026·5 min read

A New Ebola Outbreak Is Spiraling Out of Control in the Democratic Republic of the Congo

On May 5, 2025, a chilling alert was raised by health authorities in the Democratic Republic of the Congo (DRC). Four healthcare workers in the Ituri Province had died from an unidentified illness within just four days. Rapid response teams were dispatched immediately, and laboratory tests conducted at a research center in Kinshasa soon delivered a deeply troubling verdict: the Bundibugyo virus, one of the rarer but deadly pathogens belonging to the Ebola family, was responsible for the deaths.

What began as a cluster of suspicious fatalities has since snowballed into a full-scale public health emergency. By May 24, the World Health Organization (WHO) had estimated at least 223 deaths and over 900 suspected cases — and those numbers are almost certainly higher today. What makes this outbreak particularly alarming is a convergence of factors that are making it extraordinarily difficult to bring under control: no approved vaccine, escalating armed violence, and a hollowed-out global health infrastructure left vulnerable by years of funding cuts.

What Is the Bundibugyo Virus and Why Is It So Dangerous?

The Ebola disease is not caused by a single virus but by a family of related pathogens. Most people are familiar with the Zaire ebolavirus, which drove the devastating 2014–2016 West Africa epidemic that killed more than 11,000 people. That strain also caused the 2018–2020 outbreak in the DRC, which was ultimately brought under control in part through the deployment of an effective vaccine called rVSV-ZEBOV, also known as Ervebo.

The Bundibugyo virus is a different, rarer species within the same viral family. It was first identified in Uganda in 2007 and was responsible for a smaller outbreak in 2012. While it carries a similarly high fatality rate and spreads through direct contact with the bodily fluids of infected individuals, there is one critical difference: no approved vaccine exists for the Bundibugyo strain. Clinical trials for experimental vaccines are still months away from producing usable results, leaving healthcare workers and communities almost entirely without immunological protection.

This distinction is not a minor technical footnote — it is the crux of why this outbreak is proving so much harder to contain than recent Ebola events. The tools that worked before simply do not apply here.

Armed Violence Is Undermining Every Effort to Contain the Spread

Even if a vaccine existed, deploying it in Ituri Province would be a monumental challenge. The region has been afflicted by persistent armed conflict for years, and that violence is now directly interfering with the outbreak response in devastating ways.

In one of the most alarming developments, armed groups have attacked and burned down two Ebola treatment centers. These facilities, which serve as the critical infrastructure for isolating infected patients and preventing further community spread, were rendered inoperable. Even more troubling is the consequence of those attacks: at least 18 patients who were infected with the virus fled back into surrounding communities, making contact tracing an almost impossible task.

Beyond outright attacks, the broader security environment is crippling the response in subtler but equally damaging ways. Damaged roads prevent health teams from reaching remote villages where cases may be going undetected. Food insecurity is pushing people to move across borders and between communities in search of resources, potentially carrying the virus with them. Fear of armed groups means that contact tracers and healthcare workers are sometimes unable to safely enter the areas where the disease is circulating most actively.

The result is a containment strategy that is fighting on multiple fronts simultaneously, stretched thin by a crisis that is as much a security emergency as it is a health emergency.

US Funding Cuts Have Stripped Away Critical Defenses

The response to any infectious disease outbreak depends heavily on pre-existing infrastructure — surveillance systems that can detect unusual illness patterns early, stockpiles of personal protective equipment (PPE), trained field epidemiologists who know the local terrain, and functioning laboratories capable of rapidly identifying pathogens. In an ideal world, these systems operate quietly in the background, catching threats before they become crises.

In Ituri Province in 2025, that infrastructure has been significantly degraded. Years of chronic underinvestment in global health systems across sub-Saharan Africa have left surveillance networks fragile and understaffed. That underlying weakness has been compounded by steep reductions in US global health funding implemented under the Trump administration. Programs that trained local health workers, maintained disease-monitoring networks, and supplied protective equipment have been cut or eliminated entirely, leaving communities exposed at precisely the moment they need support most.

Health experts have warned for years that disinvestment in global health preparedness is not a money-saving measure — it is a gamble that is eventually called in during moments like this one, when a novel outbreak demands a rapid, well-resourced response and the systems needed to deliver it are no longer there.

What Needs to Happen Now

Containing this outbreak will require action on several fronts simultaneously. International health organizations, including the WHO and partner agencies, must surge resources into the affected region even under difficult security conditions. Diplomatic pressure and peacekeeping efforts must work to create humanitarian corridors so that health workers can operate safely. Accelerated regulatory pathways should be explored to fast-track any experimental Bundibugyo vaccines that show early promise in ongoing trials.

Perhaps most importantly, this outbreak should serve as a stark warning to governments around the world about the real cost of cutting global health funding. Outbreaks do not respect borders. A disease circulating uncontrolled in the DRC today has the potential to reach other countries tomorrow, as recent years have demonstrated repeatedly.

The Broader Lesson This Outbreak Is Teaching the World

The Bundibugyo virus outbreak in the DRC in 2025 is not simply a regional tragedy — it is a case study in how multiple systems can fail simultaneously and allow a manageable threat to become a catastrophe. No vaccine, no security, no infrastructure, no funding: each of these gaps is serious on its own. Together, they are creating a situation where one of the world's deadliest viral families is spreading with alarming speed through a population that has almost no tools to defend itself.

The international community has a narrow window to act before this outbreak grows significantly worse. The question is whether the political will exists to respond at the scale the situation demands — or whether the world will wait, as it so often has, until the cost of inaction becomes impossible to ignore.

Ebola outbreak 2025Bundibugyo virusDRC EbolaEbola containmentWHO Ebola response